Search | trudellmed.com

Based on your language, we suggest to change your settings to: En fonction de votre langue, nous vous suggérons de modifier vos paramètres comme suit :

Yes, that's correct Oui, c'est correct.

Search

Patient-Centered Airway Clearance and the Role of OPEP - man and son on bike

Patient-Centered Airway Clearance and the Role of OPEP

On June 9th 2026, the Australian Physiotherapy Association hosted a clinically focused webinar exploring Patient-Centered Airway Clearance strategies and the evolving role of Oscillating Positive Exploratory Pressure (OPEP) therapy in respiratory care.

IN THIS SESSION, WE WILL:

✓ Recognize the impact of unmanaged mucus hypersecretion

✓ Review evidence and guidelines supporting OPEP therapy use

✓ Explore differences across OPEP devices

✓ Apply insights from practical, real-world patient cases

Aerobika

AEROBIKA* OPEP Device

A drug-free and easy to use device that can help open weak airways and to loosen mucus, so it can be coughed out.

view of aerocount dose counter from top angle

AEROCOUNT* Dose Counter (TMAI)

Provides patients with a visual indication of remaining medication in their pressurized Metered Dose Inhaler (MDI).

aerocount etmai smart dose counter with bluetooth icon

AEROCOUNT* Smart Dose Counter (eTMAI)

Provides patients with a digital visual indication of remaining medication in their Metered Dose Inhaler (MDI).

Patient Centered Considerations when Selecting an Oscillating Positive Expiratory Pressure (OPEP) Device

Efficacy is a major aspect when selecting an OPEP device for airway clearance.

This study was presented at the North American Cystic Fibrosis Conference 2022.

Using Functional Respiratory Imaging (FRI) to Compare Predicted Airway Deposition Between Pressurized Metered Dose Inhaler (pMDI) with AeroChamber Plus* Flow-Vu* Valved Holding Chamber (VHC) and Two Dry Powder Inhalers (DPIs) in a COPD patient

This study was presented at the Drug Delivery to the Lungs Conference, 2022.

How Might Choice of Salbutamol Metered Dose Inhaler (MDI) Type and Use of a Spacer Impact Drug Delivery and Emissions - Best for the Patient and Environment

As current MDIs contain hydrofluorocarbon propellants, it would be beneficial to find ways to reduce carbon emissions without compromising patient safety.

This lab study investigated a way to optimize the modelled lung dose per actuation while at the same time minimizing the carbon emissions from the MDI

Medikro to distribute Aerobika* OPEP Devices to patients in Finland and Sweden.

Medikro to distribute Aerobika* OPEP Devices to patients in Finland and Sweden.

Facilitating Airway Clearance in COPD Patients During COVID-19

Join Isabelle LeClerc in this 30-minute webinar as she discusses the importance of airway clearance techniques and oscillating positive expiratory pressure (OPEP) devices, including during the COVID-19 pandemic. Please see a recording of the session below.

A National Audit of the Aerobika* Oscillatory Positive Pressure Device When Used to Assist Airway Clearance for Those With Cystic Fibrosis, Bronchiectasis and COPD

Patient use & evaluations of Aerobika* device across 23 UK Centres

RESULT: Improved CAT scores, 92% patients continuing Tx, 87% HCP (very) happy.

A National Audit of the Aerobika* Oscillatory Positive Pressure Device When Used to Assist Airway Clearance for Those With Cystic Fibrosis, Bronchiectasis and COPD

Patient use & evaluations of Aerobika* device across 23 UK Centres

RESULT: Improved CAT scores, 92% patients continuing Tx, 87% HCP (very) happy.

European Medical Journal: How a Novel Portable Spacer Benefits Patients with Respiratory Disease, the Healthcare System, and the Environment

Patient centered development of a new valved holding chamber (VHC) designed specifically for on-the-go use.

Conclusions:

The continuous involvement of patients resulted in a number of key insights that helped guide the design process, resulting in the development of a chamber that patients are much more likely to use while on-the-go.

Use of Inspiratory Profiles from Patients with Chronic Obstructive Pulmonary Disease (COPD) to Investigate Drug Delivery from a Passive Dry Powder Inhaler (DPI) Compared with a Pressurized Metered Dose (pMDI) Inhaler with Valved Holding Chamber (VHC)

RDD 2020 - E-Poster Presentation

COPD is a chronic and progressive disease that requires regular self-administration of inhaled medications. However, as the disease progresses, reduced respiratory muscle strength may prevent patients from generating sufficient inspiratory effort to effectively use dry-powder inhalers (DPIs) [1, 2]. In contrast, patients can inhale slowly or breathe tidally from a pMDI with VHC without the need to coordinate with inhaler actuation [3].

How to transition your COPD patients into 2022 and managing these COPD patients in the COVID era

Join Dr. Michael Mitar for a discussion surrounding the care of COPD patients in 2022 and overcoming obstacles in the treatment pathway presented through COVID.

By watching this webinar, you will learn about: ✓ Updated COPD guidelines ✓ New options in medications ✓ Non pharmacotherapeutic treatment options ✓ Spirometry access

Enter your information below to watch a recording of the webinar:

Patient Centered Considerations when Selecting an Oscillating Positive Expiratory Pressure (OPEP) Device

Efficacy is a major aspect when selecting an OPEP device for airway clearance.

This study was presented at the North American Cystic Fibrosis Conference 2022.

A Retrospective Cohort Study Comparing the Impact of Two Oscillating Positive Expiratory Pressure (OPEP) Devices in Patients with Chronic Obstructive Pulmonary Disease (COPD) or Chronic Bronchitis on Hospital Readmissions at 30 Days and 12 Months

Results from this study demonstrate a reduction in the proportion of patients requiring COPD/chronic bronchitis related readmission within 30 days and 12 months of the Aerobika^® OPEP device therapy initiation compared to an alternative OPEP device.
This further supports the use of the Aerobika^® OPEP device as an add-on to usual care to manage COPD/chronic bronchitis patients post-exacerbation and highlights that not all OPEP devices are the same in terms of 30-day and 12-month readmissions

How Do Different Methods of Humidification Affect Drug Delivery to a Simulated Patient Receiving Mechanical Ventilation

This study was presented at CHEST Conference 2023.

Inspiratory Profiles from Volunteer Adults who Have Read the Patient Instructions for Use for Two Passive Dry Powder Inhalers (DPIs) Compared with those from a Pressurized Metered Dose Inhaler with Valved Holding Chamber (pMDI+VHC)

This study was presented at the Drug Delivery to the Lungs, 2022.

Preferences of Patients for Portable Spacer Devices Compared to Metered Dose Inhaler Alone

Conclusion

The prototype AeroChamber2go* spacer device was preferred by patients compared to the A2A† spacer and provides a good option for patients currently using the Metered Dose Inhaler without a spacer while on-the-go.

Development of a Prototype Patient Respiratory Management Mobile Health Application Using Validated Tools to Assess User Experience

More consistent dose delivery was achieved with the breath actuated technology rather than breath enhanced. Delivering medication only when the patient inhales would result in more stable therapy if I:E ratio was to change with disease< progression or if the patient took breaks to talk during treatment.

A Retrospective Cohort Study Comparing the Impact of Two Oscillating Positive Expiratory Pressure (OPEP) Devices in Patients with Chronic Obstructive Pulmonary Disease (COPD) or Chronic Bronchitis on Hospital Readmissions at 30 Days and 12 Months

Results from this study demonstrate a reduction in the proportion of patients requiring COPD/chronic bronchitis related readmission within 30 days and 12 months of the Aerobika^® OPEP device therapy initiation compared to an alternative OPEP device.
This further supports the use of the Aerobika^® OPEP device as an add-on to usual care to manage COPD/chronic bronchitis patients post-exacerbation and highlights that not all OPEP devices are the same in terms of 30-day and 12-month readmissions

Patient-Centered Device Development of a New Portable Spacer (Valved Holding Chamber - VHC)

RDD 2020 - E-Poster Presentation

This article describes the generative, patient-centered, design process used in the development of a prototype VHC intended primarily for use ‘on the go’ by adults with persistent asthma or newly diagnosed COPD.

Webinars & Events

In-Person and Virtual Events for Patients, Consumers and Health Professionals

Drug-Free, Airway Clearance Therapies Show Positive Results in COPD

So why aren’t they used more widely?

A new review suggests that wider use of OPEP devices could reduce exacerbations and reduce hospital visits.